Skip to main content

Table 1 Main neurological symptoms reported at clinical presentation in MERS cases

From: Transient blindness associated with mild encephalitis/encephalopathy with a reversible splenial lesion (MERS): a case report and review of literature

Study Number of cases Neurological symptoms, N (% of total cases)
Consciousness disturbance (irritability, lethargy, drowsiness, delirium) Seizure Headache Dysphagia, dyslalia, slurred speech Acute urinary retention Ataxia or motor disorders Neck stiffness Hallucinations Dizziness Blurred vision Blindness
Fang Q. et al. [1] 29 18/29 (62%) 18/29 (62%) 4/29 (14%) 1/29 (3%) 1/29 (3%) 1/29 (3%) 0/29 (0%) 0/29 (0%) 0/29 (0%) 0/29 (0%) 0/7 (0%)
Pan J.J. et al. [14] 27 11/27 (41%) 5/27 (19%) 14/27 (52%) 1/27 (4%) 2/27 (7%) 1/27 (4%) 0/27 (0%) 0/27 (0%) 1/27 (4%) 2/27 (7%) 0/27 (0%)
Tada H. et al. [2] 15 12/15 (80%) 8/15 (53%) 2/15 (13%) 0/15 (0%) 0/15 (0%) 2/15 (13%) 1/15 (7%) 1/15 (7%) 2/15 (13%) 0/15 (0%) 1/15 (7%)
Ka A. et al. [3] 7 7/7 (100%) 1/7 (14%) 0/7 (0%) 3/7 (43%) 0/7 (0%) 4/7 (57%) 0/7 (0%) 2/7 (29%) 0/7 (0%) 0/7 (0%) 0/7 (0%)
Chen W.-X. et al. [11] 15 6/15 (40%) 12/15 (80%) 2/15 (13%) 2/15 (13%) 0/15 (0%) 5/15 (33%) 1/15 (7%) 1/15 (7%) 1/15 (7%) 0/15 (0%) 0/15 (0%)
Yildiz A.E. et al. [13] 8 2/8 (25%) 4/8 (50%) 1/8 (12,5%) 2/8 (25%) 0/8 (0%) 1/8 (12,5%) 2/8 (25%) 0/8 (0%) 0/8 (0%) 0/8 (0%) 2/8 (25%)
Winslow H. et al. [15] 1 0/1 (0%) 0/1 (0%) 0/1 (0%) 0/1 (0%) 0/1 (0%) 0/1 (0%) 0/1 (0%) 1/1 (100%) 0/1 (0%) 0/1 (0%) 0/1 (0%)
Lu P.L. et al. [16] 15 3/15 (20%) 3/15 (20%) 3/15 (20%) 1/15 (7%) 0/15 (0%) 1/15 (7%) 0/15 (0%) 0/15 (0%) 3/15 (20%) 2/15 (13%) 0/15 (0%)
  1. Abbreviations: MERS Mild encephalitis/encephalopathy with a reversible splenial lesion, N Number